What is Eloxx Pharmaceuticals Forward Dividend Yield %?
As of today (2024-06-07), the Forward Annual Dividend Yield of Eloxx Pharmaceuticals is 0.00%.
As of today (2024-06-07), the Trailing Annual Dividend Yield of Eloxx Pharmaceuticals is 0.00%.
ELOX's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.685 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Eloxx Pharmaceuticals's Forward Dividend Yield %
For the Biotechnology subindustry, Eloxx Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eloxx Pharmaceuticals's Forward Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Eloxx Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Eloxx Pharmaceuticals's Forward Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Eloxx Pharmaceuticals Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Eloxx Pharmaceuticals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Eloxx Pharmaceuticals (Eloxx Pharmaceuticals) Business Description
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in the science of ribosome modulation, leveraging both its ZM chemistry technology platform and its library of novel aminoglycosides to develop novel oral small molecule Ribosome Modulating Agents (RMAs) and Eukaryotic Ribosome Selective Glycosides (ERSGs), for the treatment of rare and ultra-rare genetic diseases where patients have point nonsense genetic mutations that result in premature stop codons and less than full-length proteins. The ELX-02, the company's investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELOX has been successfully added to your